Repaglinide in the treatment of diabetes.docVIP

  • 7
  • 0
  • 约1.49万字
  • 约 13页
  • 2017-05-05 发布于浙江
  • 举报
Repaglinide in the treatment of diabetes

 PAGE \* MERGEFORMAT 13 Repaglinide in the treatment of diabetes [Keywords:] repaglinide Diabetes Non-sulfonylurea insulin secretion agent (Non-sulfonylureas, NSUR), also known as “prandial glucose regulator”, repaglinide (repaglinide) is one of the representatives. Repaglinide is a carbamoyl benzene acid derivatives, structure and traditions very different sulfonylurea drugs, can effectively control type 2 diabetes after meal glucose fluctuations, while significantly reducing the incidence of severe hypoglycemia, sulfonylureas overcome the above defects. Pharmacological properti

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档